Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Phio Pharmaceuticals Corp. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 707.5K | 779.5K | +72.0K (+10.2%) |
| Value | $626.0K | $551.0K | −$75.0K (−12.0%) |
New holders (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 27,793 | $20.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 8,183 | $6.00K | 0.00% |
| Simplex Trading, LLC | 398 | $0 | 0.00% |
Sold out (5)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Advisers, LP | 46,700 | $41.0K |
| Millennium Management LLC | 10,241 | $9.00K |
| UBS Group AG | 2,685 | $2.00K |
| Citigroup Inc | 1,000 | $1.00K |
| Group One Trading, L.P. | 300 | $0 |